Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments

GERMANTOWN, Md., Oct. 27, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company will host a virtual event on Thursday,...